{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T16:05:49Z","timestamp":1791389149332,"version":"4.3.3"},"reference-count":43,"publisher":"Wiley","issue":"4","license":[{"start":{"date-parts":[[2005,8,24]],"date-time":"2005-08-24T00:00:00Z","timestamp":1124841600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinical Endocrinology"],"published-print":{"date-parts":[[2005,10]]},"abstract":"<jats:title>Summary<\/jats:title><jats:p><jats:bold>Objective\u2002<\/jats:bold> Ocular diseases markedly impair daily function. In Graves\u2019 orbitopathy (GO), an associated psychosocial burden is present due to disfiguring proptosis and\/or diplopia, signs with significant impact on functional status and well\u2010being. We have therefore surveyed and assessed the psychosocial morbidity of GO.<\/jats:p><jats:p><jats:bold>Design\u2002<\/jats:bold> A prospective controlled study on subjects with GO using internationally validated, self\u2010reporting questionnaires.<\/jats:p><jats:p><jats:bold>Patients\u2002<\/jats:bold> One hundred and two consecutive patients with varying degrees of severity and activity of GO.<\/jats:p><jats:p><jats:bold>Measurements\u2002<\/jats:bold> Emotional distress, coping styles and quality of life (QoL) were assessed by the Hospital Anxiety and Depression Scale, by a German adaptation of the Ways\u2010of\u2010Coping Checklist, and with the 36\u2010item Short Form, respectively. Stressful events in the 6\u00a0months preceding diagnosis were registered with the Life Experience Survey. QoL findings were compared to German reference values, as well as to 102 age\u2010 and gender\u2010matched patients, each with type\u00a01 diabetes (insulin\u2010dependent diabetes mellitus, IDDM) and inflammatory bowel disease (IBD), respectively.<\/jats:p><jats:p><jats:bold>Results\u2002<\/jats:bold> Compared to the German reference population, all QoL scales were at a lower rate and were especially decreased in subjects with active and\/or severe GO, orbital pain, diplopia and stressful life events. Compared to diabetics, psychosocial scales were considerably reduced in GO (<jats:italic>z<\/jats:italic>\u00a0=\u00a0\u22121 <jats:italic>vs.<\/jats:italic> 0\u00b71, <jats:italic>P<\/jats:italic>\u00a0&lt;\u00a00\u00b7001) and higher scores for depressive coping (2\u00b732 <jats:italic>vs.<\/jats:italic> 1\u00b771, <jats:italic>P<\/jats:italic>\u00a0&lt;\u00a00\u00b7001) and trivializing (2\u00b737 <jats:italic>vs.<\/jats:italic> 1\u00b797, <jats:italic>P<\/jats:italic>\u00a0&lt;\u00a00\u00b7006) were noted. In GO, depressive coping and trivializing were negatively correlated with the mental (<jats:italic>r<\/jats:italic>\u00a0=\u00a0\u22120\u00b7603 and <jats:italic>r<\/jats:italic>\u00a0=\u22120\u00b7411, both <jats:italic>P<\/jats:italic>\u00a0&lt;\u00a00\u00b7001) and physical (<jats:italic>r<\/jats:italic>\u00a0=\u00a0\u22120\u00b7487 and <jats:italic>r<\/jats:italic>\u00a0=\u00a0\u22120\u00b7354, both <jats:italic>P<\/jats:italic>\u00a0&lt;\u00a00\u00b7001) components of QoL. Depressive coping also positively correlated with anxiety (<jats:italic>r<\/jats:italic>\u00a0=\u00a00\u00b7636) and depression (<jats:italic>r<\/jats:italic>\u00a0=\u00a00\u00b7590), respectively, both <jats:italic>P<\/jats:italic>\u00a0&lt;\u00a00\u00b7001. Emotional distress noted in 46 subjects, mostly with active and severe GO, was associated with poor QoL. Anxiety and depression were present in 41 and 24 GO patients, respectively. The number of stressful events positively correlated with the scores of anxiety (<jats:italic>r<\/jats:italic>\u00a0= 0\u00b73335) and depression (<jats:italic>r<\/jats:italic>\u00a0= 0\u00b73178), both <jats:italic>P<\/jats:italic>\u00a0=\u00a00\u00b7001. Foremost emotional distress, but also diplopia, stressful events and depressive coping had a major impact on QoL (proportion of variance explained\u00a0=\u00a013\u00b71%, <jats:italic>P<\/jats:italic>\u00a0&lt;\u00a00\u00b7001, multiple regression analysis). More than 75% of the psychosocial impairment in GO (<jats:italic>R<\/jats:italic><jats:sup>2<\/jats:sup>\u00a0=\u00a00\u00b776, <jats:italic>P<\/jats:italic>\u00a0&lt;\u00a00\u00b7001) was associated with seven variables only (e.g. depression and anxiety). Six months prior to GO onset, 74 patients experienced a mean of 4\u00a0(range 0\u201313) stressful life events. Subjects with optic neuropathy had more stressful events than those without nerve involvement (5\u00b71 <jats:italic>vs.<\/jats:italic> 2\u00b77, <jats:italic>P<\/jats:italic>\u00a0=\u00a00\u00b70425).<\/jats:p><jats:p><jats:bold>Conclusions\u2002<\/jats:bold> Psychosocial morbidity is present in severe and\/or active GO, which negatively affects QoL. The patients are not only physically ill, they also exhibit emotional distress. Accompanying psychosomatic treatment is indicated among about half of all GO patients.<\/jats:p>","DOI":"10.1111\/j.1365-2265.2005.02352.x","type":"journal-article","created":{"date-parts":[[2005,8,24]],"date-time":"2005-08-24T10:17:58Z","timestamp":1124878678000},"page":"395-402","source":"Crossref","is-referenced-by-count":152,"title":["Psychosocial morbidity of Graves\u2019 orbitopathy"],"prefix":"10.1111","volume":"63","author":[{"given":"G. J.","family":"Kahaly","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Petrak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Hardt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Pitz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"U. T.","family":"Egle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2005,8,24]]},"reference":[{"key":"e_1_2_6_2_2","first-page":"710","article-title":"Medicine and the quality of life","volume":"64","author":"Elkinton J.R.","year":"1966","journal-title":"Annals of Internal Medicine"},{"key":"e_1_2_6_3_2","doi-asserted-by":"publisher","DOI":"10.1016\/0738-3991(95)00734-H"},{"key":"e_1_2_6_4_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.1994.03520080061045"},{"key":"e_1_2_6_5_2","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1001\/jama.1997.03540390062037","article-title":"Users\u2019 guides to the medical literature. XII. How to use articles about health\u2010related quality of life. Evidence\u2010Based Medicine Working Group","volume":"277","author":"Guyatt G.H.","year":"1997","journal-title":"Journal of the American Medical Association"},{"key":"e_1_2_6_6_2","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1001\/jama.1989.03430070055030","article-title":"Functional status and well\u2010being of patients with chronic conditions. Results from the Medical Outcomes Study","volume":"262","author":"Stewart A.L.","year":"1989","journal-title":"Journal of the American Medical Association"},{"key":"e_1_2_6_7_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199603283341306"},{"key":"e_1_2_6_8_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.1995.03520250075037"},{"key":"e_1_2_6_9_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.metabol.2003.07.008"},{"key":"e_1_2_6_10_2","doi-asserted-by":"publisher","DOI":"10.1089\/thy.1997.7.613"},{"key":"e_1_2_6_11_2","doi-asserted-by":"publisher","DOI":"10.1023\/A:1008927809013"},{"key":"e_1_2_6_12_2","doi-asserted-by":"publisher","DOI":"10.1001\/archopht.1994.01090150059023"},{"key":"e_1_2_6_13_2","doi-asserted-by":"publisher","DOI":"10.1210\/er.21.2.168"},{"key":"e_1_2_6_14_2","doi-asserted-by":"publisher","DOI":"10.1089\/thy.1997.7.885"},{"key":"e_1_2_6_15_2","doi-asserted-by":"publisher","DOI":"10.1177\/112067210401400302"},{"key":"e_1_2_6_16_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0161-6420(97)30303-0"},{"key":"e_1_2_6_17_2","doi-asserted-by":"publisher","DOI":"10.1080\/003655201300051171"},{"key":"e_1_2_6_18_2","doi-asserted-by":"publisher","DOI":"10.1002\/dmrr.374"},{"key":"e_1_2_6_19_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2265.2001.01349.x"},{"key":"e_1_2_6_20_2","doi-asserted-by":"publisher","DOI":"10.1530\/eje.0.1480491"},{"key":"e_1_2_6_21_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2249.2004.02750.x"},{"key":"e_1_2_6_22_2","doi-asserted-by":"publisher","DOI":"10.2307\/2982889"},{"key":"e_1_2_6_23_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.305.6861.1074"},{"key":"e_1_2_6_24_2","doi-asserted-by":"publisher","DOI":"10.1097\/00005650-199704000-00010"},{"key":"e_1_2_6_25_2","doi-asserted-by":"publisher","DOI":"10.1097\/00005650-199206000-00002"},{"key":"e_1_2_6_26_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0895-4356(98)00107-3"},{"key":"e_1_2_6_27_2","volume-title":"Freiburger Fragebogen Zur Krankheitsverarbeitung, FKV.","author":"Muthny F.A.","year":"1989"},{"key":"e_1_2_6_28_2","unstructured":"Herrmann C. Buss U.&Snaith R.P.(1995) HADS\u2010D. Hospital anxiety and depression scale."},{"key":"e_1_2_6_29_2","doi-asserted-by":"publisher","DOI":"10.1037\/0022-006X.46.5.932"},{"key":"e_1_2_6_30_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF02959944"},{"key":"e_1_2_6_31_2","volume-title":"Graves\u2019 Ophthalmopathy","author":"Terwee C.B.","year":"2001"},{"key":"e_1_2_6_32_2","doi-asserted-by":"publisher","DOI":"10.1136\/bjo.82.7.773"},{"key":"e_1_2_6_33_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0895-4356(99)00069-4"},{"key":"e_1_2_6_34_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2265.2001.01241.x"},{"key":"e_1_2_6_35_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2265.1995.tb01879.x"},{"key":"e_1_2_6_36_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2265.1998.00528.x"},{"key":"e_1_2_6_37_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-118-8-199304150-00009"},{"key":"e_1_2_6_38_2","doi-asserted-by":"publisher","DOI":"10.1192\/bjp.161.4.535"},{"key":"e_1_2_6_39_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2265.2001.01332.x"},{"key":"e_1_2_6_40_2","first-page":"293","article-title":"Life events in the pathogenesis of Graves\u2019 disease. A controlled study","volume":"128","author":"Sonino N.","year":"1993","journal-title":"Acta Endocrinologica"},{"key":"e_1_2_6_41_2","doi-asserted-by":"publisher","DOI":"10.1016\/0140-6736(91)92298-G"},{"key":"e_1_2_6_42_2","doi-asserted-by":"publisher","DOI":"10.1097\/00006842-199803000-00013"},{"key":"e_1_2_6_43_2","doi-asserted-by":"publisher","DOI":"10.1097\/00006842-199809000-00014"},{"key":"e_1_2_6_44_2","doi-asserted-by":"publisher","DOI":"10.1089\/thy.1998.8.37"}],"container-title":["Clinical Endocrinology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2265.2005.02352.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1365-2265.2005.02352.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,13]],"date-time":"2023-10-13T18:22:11Z","timestamp":1697221331000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1365-2265.2005.02352.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,8,24]]},"references-count":43,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2005,10]]}},"alternative-id":["10.1111\/j.1365-2265.2005.02352.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1365-2265.2005.02352.x","archive":["Portico"],"relation":{},"ISSN":["0300-0664","1365-2265"],"issn-type":[{"value":"0300-0664","type":"print"},{"value":"1365-2265","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,8,24]]}}}